Psoriasis: a possible risk factor for development of coronary artery calcification

被引:274
作者
Ludwig, R. J.
Herzog, C.
Rostock, A.
Ochsendorf, F. R.
Zollner, T. M.
Thaci, D.
Kaufmann, R.
Vogl, T. J.
Boehncke, W-H.
机构
[1] Goethe Univ Frankfurt, Dept Dermatol, D-60590 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Dept Radiol, D-60590 Frankfurt, Germany
关键词
cardiovascular diseases; inflammation; psoriasis; spiral computed tomography;
D O I
10.1111/j.1365-2133.2006.07562.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Psoriasis is a chronic inflammatory skin disorder affecting about 2% of white-skinned individuals. Epidemiological data on the prevalence and degree of coronary artery calcification (CAC) as an indicator for cardiovascular diseases in patients with psoriasis are contradictory. Objectives To study the prevalence and degree of CAC as an indicator for cardiovascular diseases in 32 patients with psoriasis matched for age, sex and risk factors to an equally sized control population. Methods Noncontrast-enhanced 16-row spiral computed tomography was performed in patients and controls. Results We found a significantly increased prevalence (59.4% vs. 28.1%, P = 0.015) and severity (CAC score according to Agatston 3.7 vs. 0.0, P = 0.019) of CAC in patients with psoriasis. Multiple linear regression calculations identified psoriasis as a likely independent risk factor for CAC. Conclusions Our results point towards the potentially systemic nature of the inflammatory processes underlying the pathogenesis of psoriasis, which may therefore be considered a potentially severe systemic disease.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 28 条
  • [1] QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY
    AGATSTON, AS
    JANOWITZ, WR
    HILDNER, FJ
    ZUSMER, NR
    VIAMONTE, M
    DETRANO, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) : 827 - 832
  • [2] Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E - The St. Francis Heart Study Randomized Clinical Trial
    Arad, Y
    Spadaro, LA
    Roth, M
    Newstein, D
    Guerci, AD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) : 166 - 172
  • [3] Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events - The St. Francis Heart Study
    Arad, Y
    Goodman, KJ
    Roth, M
    Newstein, D
    Guerci, AD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) : 158 - 165
  • [4] Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo
    Bhagat, K
    Vallance, P
    [J]. CIRCULATION, 1997, 96 (09) : 3042 - 3047
  • [5] STATISTICAL ASSOCIATION BETWEEN PSORIASIS AND DIABETES - FURTHER RESULTS
    BINAZZI, M
    CALANDRA, P
    LISI, P
    [J]. ARCHIV FUR DERMATOLOGISCHE FORSCHUNG, 1975, 254 (01): : 43 - 48
  • [6] Interfering with leukocyte rolling -: a promising therapeutic approach in inflammatory skin disorders?
    Boehncke, WH
    Schön, MP
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) : 49 - 52
  • [7] Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden
    Boffetta, P
    Gridley, G
    Lindelöf, B
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) : 1531 - 1537
  • [8] The impact of the inflammatory response on coagulation
    Esmon, CT
    [J]. THROMBOSIS RESEARCH, 2004, 114 (5-6) : 321 - 327
  • [9] Heart rate adaptive optimization of spatial and temporal resolution for electrocardiogram-gated multislice spiral CT of the heart
    Flohr, T
    Ohnesorge, B
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2001, 25 (06) : 907 - 923
  • [10] Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs
    Fukumoto, Y
    Shimokawa, H
    Ito, A
    Kadokami, T
    Yonemitsu, Y
    Aikawa, M
    Owada, MK
    Egashira, K
    Sueishi, K
    Nagai, R
    Yazaki, Y
    Takeshita, A
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (02) : 222 - 231